Cargando…

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study

BACKGROUND: Pituitary adenylate cyclase-activating peptide (PACAP) and vasoactive intestinal peptide (VIP) provoked cluster headache attacks in individuals with episodic cluster headache during their active phase and individuals with chronic cluster headache. In this study, we investigated whether i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deligianni, Christina, Pellesi, Lanfranco, Chaudhry, Basit Ali, Haulund Vollesen, Anne Luise, Snoer, Agneta Henriette, Hannibal, Jens, Jensen, Rigmor Højland, Ashina, Messoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151752/ https://www.ncbi.nlm.nih.gov/pubmed/37143998 http://dx.doi.org/10.3389/fneur.2023.1135246

Ejemplares similares

Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study
por: Pellesi, Lanfranco, et al.
Publicado: (2022)

Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
por: Schytz, Henrik Winther, et al.
Publicado: (2010)

PACAP38 in human models of primary headaches
por: Ashina, Håkan, et al.
Publicado: (2017)

Signal Transduction by VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2022)

Migraine and cluster headache – the common link
por: Vollesen, Anne Luise, et al.
Publicado: (2018)

The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study
por: Rasmussen, Nadja Bredo, et al.
Publicado: (2023)

Correction: The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study
por: Rasmussen, Nadja Bredo, et al.
Publicado: (2023)

Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2021)

PACAP and VIP Neuropeptides’ and Receptors’ Effects on Appetite, Satiety and Metabolism
por: Vu, John P., et al.
Publicado: (2023)

Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
por: Lu, Jessica, et al.
Publicado: (2022)

Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP
por: Temerozo, Jairo R., et al.
Publicado: (2013)

Adipose Tissue Expression of PACAP, VIP, and Their Receptors in Response to Cold Stress
por: Cline, Daemon L., et al.
Publicado: (2018)

Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP
por: Liao, Chenyi, et al.
Publicado: (2021)

Reducing Episodic Cluster Headaches: Focus on Galcanezumab
por: Pellesi, Lanfranco, et al.
Publicado: (2020)

The economic and personal burden of cluster headache: a controlled cross-sectional study
por: Petersen, Anja Sofie, et al.
Publicado: (2022)

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)

Agnathan VIP, PACAP and Their Receptors: Ancestral Origins of Today's Highly Diversified Forms
por: Ng, Stephanie Y. L., et al.
Publicado: (2012)

PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
por: Broome, Sarah Thomas, et al.
Publicado: (2022)

From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
por: Tanaka, Masaru, et al.
Publicado: (2023)

Triptans and CGRP blockade – impact on the cranial vasculature
por: Benemei, Silvia, et al.
Publicado: (2017)

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
por: Ashina, Messoud, et al.
Publicado: (2018)

Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration
por: Woodley, Patricia K., et al.
Publicado: (2019)

Messenger RNA Gene Expression Screening of VIP and PACAP Neuropeptides and Their Endogenous Receptors in Ruminants
por: Hawley, Emma, et al.
Publicado: (2022)

Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
por: Jansen, Margo I., et al.
Publicado: (2022)

Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction
por: Yan, Xiang, et al.
Publicado: (2023)

Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury
por: Broome, Sarah Thomas, et al.
Publicado: (2023)

VIP Visit
Publicado: (1998)

VIP Visit
Publicado: (1999)

PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression
por: Maugeri, Grazia, et al.
Publicado: (2016)

Expression and significance of TIMP-3, PACAP and VIP in vaginal wall tissues of patients with stress urinary incontinence
por: Fan, Bo, et al.
Publicado: (2017)

Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial
por: Pellesi, Lanfranco, et al.
Publicado: (2021)

PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP
por: Bensalma, Souheyla, et al.
Publicado: (2019)

Potential Crosstalk between the PACAP/VIP Neuropeptide System and Endoplasmic Reticulum Stress—Relevance to Multiple Sclerosis Pathophysiology
por: Withana, Minduli, et al.
Publicado: (2023)

Cluster headache – The worst possible pain on YouTube
por: Chaudhry, Basit Ali, et al.
Publicado: (2022)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus
por: Lee, Jayden, et al.
Publicado: (2023)

The Circadian Clock Is Sustained in the Thyroid Gland of VIP Receptor 2 Deficient Mice
por: Georg, Birgitte, et al.
Publicado: (2021)

Egypt VIP visit CMS
por: Hoch, Michael
Publicado: (2010)

Visitors: VIP-visits: 2003
Publicado: (2003)

Visitors: VIP-visits: 2003
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_9gujdg4fk88h5k2v2l241rsios